Search results :

Tolvaptan

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: C03XA01

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2
Thirst very common, 15.7% 5% x x
Nausea very common x x
Polyuria common, 11.2% 3.18% x x
Pollakiuria common, 11.2% 3.18% x x
Asthenia common, 8.52% 4.09% x x
Constipation common, 7.17% 1.82% x x
Hyperglycaemia common, 6.28% 0.909% x x
Dehydration common x
Diarrhoea common x
Dizziness common x
Ecchymosis common x
Headache common x
Hyperkalaemia common x
Hypoglycaemia common x
Orthostatic hypotension common x
Pruritus common x
Syncope common x
Dry mouth common x x
Polydipsia common x
Aspartate aminotransferase increased common x
Alanine aminotransferase increased common x
Malaise common x
Decreased appetite common x
Neurological symptom common x
Blood creatinine increased common x
Hyperuricaemia common x
Blood urine present common x
Body temperature increased common, 4.04% 0.909% x x
Anorexia 3.59% 0.909% x
Dysgeusia uncommon x
Prurigo uncommon x
Blood bilirubin increased uncommon x
Renal impairment uncommon x
Anaphylactic shock postmarketing x
Hypernatraemia postmarketing, common x x
Hypersensitivity postmarketing x
Immune system disorder postmarketing x
Rash generalised postmarketing x
Hyponatraemic postmarketing x
Osmotic demyelination syndrome postmarketing x
Breast disorder x
Connective tissue disorder x
Diabetic ketoacidosis x
Disseminated intravascular coagulation x
Gastrointestinal disorder x x
Gastrointestinal haemorrhage x
Cardiac disorder x
Mediastinal disorder x
Nervous system disorder x
Pulmonary embolism x
Rhabdomyolysis x
Cerebrovascular accident x
Urinary tract disorder x x
Angiopathy x x
Ventricular fibrillation x
Deep vein thrombosis x
Prothrombin level increased x
Malnutrition x x
Colitis ischaemic x
Unspecified disorder of skin and subcutaneous tissue x
Urethral haemorrhage x
Blood and lymphatic system disorders x
Intracardiac thrombus x
Respiratory failure x
Vaginal haemorrhage x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

tolvaptan / tolvaptan

Side effects:39
Source:EMA

tolvaptan

Side effects:40
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label